Target intelligence / Profile preview

Transient receptor potential melastatin channel TRPMPZQ (TRPMPZQ)

Target
TRPMPZQ
Molecular classification
Ion channel, Transient receptor potential channel, TRPM channel, Non-selective cation channel
01

Overview

Transient receptor potential melastatin channel TRPMPZQ (TRPMPZQ) is a parasite-specific, non-selective cation channel belonging to the transient receptor potential melastatin (TRPM) subfamily. It serves as the primary molecular target for the anthelmintic drug praziquantel (PZQ), which is widely used to treat schistosomiasis and other parasitic flatworm infections. TRPMPZQ is expressed in the muscle, nervous tissues, and sensory structures of parasitic flatworms like Schistosoma mansoni. Upon activation by praziquantel, the channel mediates a rapid and sustained influx of extracellular calcium (Ca2+) and sodium (Na+) ions, leading to membrane depolarization, spastic muscle paralysis, and severe damage to the parasite's tegument, ultimately resulting in worm death. Variations in the TRPMPZQ gene sequence or expression levels are directly linked to differences in drug sensitivity across different flatworm species and life cycle stages. For instance, the insensitivity of Fasciola hepatica (liver fluke) to praziquantel is attributed to a single amino acid difference in the TRPMPZQ binding pocket. Additionally, down-regulation or specific single nucleotide polymorphisms (SNPs) in TRPMPZQ have been associated with laboratory-selected praziquantel resistance, making the channel a critical focus for monitoring drug resistance and developing next-generation anthelmintics.

Other names
Sm.TRPMPZQSm.TRPM_PZQPraziquantel-activated TRP channelPraziquantel target TRP channelTRPM-PZQTransient receptor potential melastatin channel PZQ
02

Mechanism of action

Agonism (channel activation leading to calcium influx)

03

Biological functions

Calcium transportCation transportSensory transductionMuscle contractionNeuromuscular signalingOther
04

Disease associations

InfectionSchistosomiasisHelminthiasisOther
05

Safety considerations

Drug resistance due to TRPMPZQ mutations or down-regulationLack of efficacy against juvenile/immature worms due to developmental expression differencesInsensitivity in certain flatworm species (e.g., Fasciola hepatica) due to sequence variation in the binding pocket
06

Interacting drugs

3 more in the full profile.

07

Biomarkers

TRPMPZQ expression levelTRPMPZQ single nucleotide polymorphisms (SNPs)TRPMPZQ sequence variants

Beyond the preview

Go deeper on Transient receptor potential melastatin channel TRPMPZQ (TRPMPZQ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transient receptor potential melastatin channel TRPMPZQ (TRPMPZQ).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call